Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 165

1.

Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study.

Marshall RD, Beebe KL, Oldham M, Zaninelli R.

Am J Psychiatry. 2001 Dec;158(12):1982-8.

PMID:
11729013
[PubMed - indexed for MEDLINE]
2.

Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial.

Tucker P, Zaninelli R, Yehuda R, Ruggiero L, Dillingham K, Pitts CD.

J Clin Psychiatry. 2001 Nov;62(11):860-8.

PMID:
11775045
[PubMed - indexed for MEDLINE]
3.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
[PubMed - indexed for MEDLINE]
4.

A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults.

Marshall RD, Lewis-Fernandez R, Blanco C, Simpson HB, Lin SH, Vermes D, Garcia W, Schneier F, Neria Y, Sanchez-Lacay A, Liebowitz MR.

Depress Anxiety. 2007;24(2):77-84.

PMID:
16892419
[PubMed - indexed for MEDLINE]
5.

Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial.

Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum B, Sikes CR, Farfel GM.

JAMA. 2000 Apr 12;283(14):1837-44.

PMID:
10770145
[PubMed - indexed for MEDLINE]
6.

Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study.

Davidson J, Pearlstein T, Londborg P, Brady KT, Rothbaum B, Bell J, Maddock R, Hegel MT, Farfel G.

Am J Psychiatry. 2001 Dec;158(12):1974-81.

PMID:
11729012
[PubMed - indexed for MEDLINE]
7.

Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.

Robert S, Hamner MB, Ulmer HG, Lorberbaum JP, Durkalski VL.

J Clin Psychiatry. 2006 Oct;67(10):1522-6.

PMID:
17107242
[PubMed - indexed for MEDLINE]
8.

Controlled-release paroxetine in the treatment of patients with social anxiety disorder.

Lepola U, Bergtholdt B, St Lambert J, Davy KL, Ruggiero L.

J Clin Psychiatry. 2004 Feb;65(2):222-9.

PMID:
15003077
[PubMed - indexed for MEDLINE]
9.

Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial.

Davidson J, Baldwin D, Stein DJ, Kuper E, Benattia I, Ahmed S, Pedersen R, Musgnung J.

Arch Gen Psychiatry. 2006 Oct;63(10):1158-65.

PMID:
17015818
[PubMed - indexed for MEDLINE]
10.

Fluoxetine versus placebo in posttraumatic stress disorder.

Martenyi F, Brown EB, Zhang H, Prakash A, Koke SC.

J Clin Psychiatry. 2002 Mar;63(3):199-206.

PMID:
11926718
[PubMed - indexed for MEDLINE]
11.

A pooled analysis of gender and trauma-type effects on responsiveness to treatment of PTSD with venlafaxine extended release or placebo.

Rothbaum BO, Davidson JR, Stein DJ, Pedersen R, Musgnung J, Tian XW, Ahmed S, Baldwin DS.

J Clin Psychiatry. 2008 Oct;69(10):1529-39.

PMID:
19192435
[PubMed - indexed for MEDLINE]
12.

Efficacy of controlled-release paroxetine in the treatment of late-life depression.

Rapaport MH, Schneider LS, Dunner DL, Davies JT, Pitts CD.

J Clin Psychiatry. 2003 Sep;64(9):1065-74.

PMID:
14628982
[PubMed - indexed for MEDLINE]
13.

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.

Eur Neuropsychopharmacol. 2004 Dec;14(6):457-70.

PMID:
15589385
[PubMed - indexed for MEDLINE]
14.

Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.

Brady KT, Clary CM.

Compr Psychiatry. 2003 Sep-Oct;44(5):360-9.

PMID:
14505296
[PubMed - indexed for MEDLINE]
15.

An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder.

Marshall RD, Schneier FR, Fallon BA, Knight CB, Abbate LA, Goetz D, Campeas R, Liebowitz MR.

J Clin Psychopharmacol. 1998 Feb;18(1):10-8.

PMID:
9472837
[PubMed - indexed for MEDLINE]
16.

A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.

Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.

Depress Anxiety. 2007;24(1):1-14.

PMID:
16894619
[PubMed - indexed for MEDLINE]
17.

Clinical evaluation of paroxetine in post-traumatic stress disorder (PTSD): 52-week, non-comparative open-label study for clinical use experience.

Kim Y, Asukai N, Konishi T, Kato H, Hirotsune H, Maeda M, Inoue H, Narita H, Iwasaki M.

Psychiatry Clin Neurosci. 2008 Dec;62(6):646-52. doi: 10.1111/j.1440-1819.2008.01862.x.

PMID:
19068000
[PubMed - indexed for MEDLINE]
18.

Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

Perahia DG, Wang F, Mallinckrodt CH, Walker DJ, Detke MJ.

Eur Psychiatry. 2006 Sep;21(6):367-78. Epub 2006 May 11.

PMID:
16697153
[PubMed - indexed for MEDLINE]
19.
20.

Nefazodone in patients with treatment-refractory posttraumatic stress disorder.

Zisook S, Chentsova-Dutton YE, Smith-Vaniz A, Kline NA, Ellenor GL, Kodsi AB, Gillin JC.

J Clin Psychiatry. 2000 Mar;61(3):203-8.

PMID:
10817106
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk